Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases

Journal of the National Cancer Institute

Volumn 92, Issue 9, 2000, Pages 729-736

  Judde, Jean Gabriel ^a   Lacoste, Vincent ^a   Brière, Josette ^b   Kassa Kelembho, Eric ^d   Clyti, Emmanuel ^d   Couppié, Pierre ^d   Buchrieser, Carmen ^a   Tulliez, Micheline ^c   Morvan, Jacques ^d   Gessain, Antoine ^a  

^a INSTITUT PASTEUR   (France)

^b Hopital Laennec   (France)

^c Université Paris Descartes   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; VIRUS DNA;

ADULT; AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CLONE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; KAPOSI SARCOMA; LONG TERMINAL REPEAT; LYMPHOMA; MALE; MARKER GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS REPLICATION;

EID: 0034600309     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.9.729     Document Type: Article

References (50)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
2. Russo JJ, Bohenzky RA, Chien MC, Chen J, Van M, Maddalena D, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996;93:14862-7.
3. Rose TM, Strand KB, Schultz ER, Schaefer G, Rankin GW Jr, Thouless ME, et al. Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J Virol 1997;71:4138-44.
4. Fleckenstein B, Desrosiers RC. Herpesvirus saimiri and herpesvirus ateles. In: Roizman B, editor. The herpesviruses. New York (NY): Plenum Press; 1982. p. 253-332.
5. Miller G, Epstein-Barr virus. Biology, pathogenesis and medical aspects. In: Fields BN, Knipe DM, editors. Fields' virology. New York (NY): Raven Press; 1990. p. 1921-58.
6. Schulz TF. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 1998;79:1573-91.
7. Neipel F, Fleckenstein B. The role of HHV-8 in Kaposi's sarcoma. Semin Cancer Biol 1999;9:151-64.
8. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88: 645-56.
9. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Bahinet P, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
10. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995;1:1274-8.
11. Kennedy MM, Cooper K, Howells DD, Picton S, Biddolph S, Lucas SB, et al. Identification of HHV8 in early Kaposi's sarcoma: implications for Kaposi's sarcoma pathogenesis. Mol Pathol 1998;51:14-20.
12. Decker LL, Shankar P, Khan G, Freeman RB, Dezube BJ, Lieberman J, et al. The Kaposi sarcoma-assuciated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 1996;184:283-8.
13. Renne R, Lagunoff M, Zhong W, Ganem D. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 1996;70:8151-4.
14. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994;77:791-3.
15. Li M, Lee H, Yoon DW, Albrecht JC, Fleckenstein B, Neapel F, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol 1997;71:1984-91.
16. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 1998; 72:1005-12.
17. Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 1999;190:1025-32.
18. Mesri EA. Inflammatory reactivation and angiogenicity of Kaposi's sarcoma-associated herpesvirus/HHV8: a missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Blood 1999;93:4031-3.
19. Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 1999;93:4034-43.
20. Drexler HG, Uphoff CC, Gaidano G, Carbone A. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia 1998;12:1507-17.
21. Soulier J, Grollet L, Oksenhendler E, Miclea JM, Cacoub P, Baruchel A, et al. Molecular analysis of clonality in Castleman's disease. Blood 1995;86: 1131-8.
22. Rabkin CS, Bedi G, Musaba E, Sunkutu R, Mwansa N, Sidransky D, et al. AIDS-related Kaposi's sarcoma is a clonal neoplasm. Clin Cancer Res 1995;1:257-60.
23. Rabkin CS, Janz S, Lash A, Coleman AE, Musaba E, Liotta L, et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997;336:988-93.
24. Delabesse E, Oksenhendler E, Lebbe C, Verola O, Varet B, Turhan AG. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol 1997; 50:664-8.
25. Gill P, Tsai Y, Rao AP, Jones P. Clonality in Kaposi's sarcoma. N Engl J Med 1997;337:570-1.
26. Diaz-Cano SJ, Wolfe HJ. Clonality in Kaposi's sarcoma. N Engl J Med 1997;337:571-2.
27. rd, Zheng T, Harrington WA Jr, et al. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci USA 1998;95:8257-61.
28. Lagunoff M, Ganem D. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 1997; 236:147-54.
29. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-9.
30. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT, et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 1991; 77:1092-5.
31. Lacoste V, Judde JG, Bestetti G, Cadranel J, Antoine M, Valensi F, et al. Virologicai and molecular characterization of a new B lymphoid cell line. established from a pleural effusion of an AIDS patient with primary effusion lymphoma, harboring both KSHV/HHV-8 and EBV viruses. Leuk Lymphoma. In press 2000.
32. Poole LJ, Zong JC, Ciufo DM, Alcendor DJ, Cannon JS, Ambinder R, et al. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for iwo distinct types of open reading frame K15 alleles at the right-hand end. J Virol 1999;73:6646-60.
33. Fouchard N, Lacoste V, Couppie P, Develoux M, Mauclere P, Michel P, et al. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America. Int J Cancer 2000;85:166-70.
34. Gessain A, Briere J, Angelin-Dudos C, Valensi F, Beral HM, Davi F, et al. Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas. Leukemia 1997;11: 266-72.
35. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995;86:2708-14.
36. Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, Knowles DM, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996;88:2648-54.
37. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996;2:342-6.
38. Gaidano G, Capello D, Cilia AM, Gloghini A, Perin T, Quattrone S, et al. Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis. Genes Chromosomes Cancer 1999;24:16-23.
39. Barile G, Di Certo MG, Cirone M, Frati L, Pontieri GM, Faggioni A, et al. Events related to Epstein-Barr virus binding and superinfection of Raji cells. Intervirology 1994;37:245-51.
40. Takimoto T, Sato H, Ogura H, Miyawaki T, Glaser R. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor. Cancer Res 1986;46: 2541-4.
41. Sato H, Takimoto T, Tanaka S, Tanaka J, Raab-Traub N. Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J Virol 1990;64:5295-300.
42. Brooks JJ. Kaposi's sarcoma: a reversible hyperplasia. Lancet 1986;2: 1309-11.
43. Reitz MS Jr, Nerurkar LS, Gallo RC. Perspective on Kaposi's sarcoma: facts, concepts, and conjectures. J Natl Cancer Inst 1999;91:1453-8.
44. Gale RE, Wheadon H, Boulos P, Linch DC. Tissue specificity of X-chromosome inactivation patterns. Blood 1994;83:2899-905.
45. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 1999;96:4546-51.
46. Moses AV, Fish KN, Ruhl R, Smith PP, Strussenberg JG, Zhu L, et al. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol 1999;73:6892-902.
47. Parravinci C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 1997;151:1517-22.
48. Yoshizaki K, Matsuda T, Nishimolo N, Kuritani T, Taeho L, Aozasa K, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989;74:1360-7.
49. Leger-Ravet MB, Peuchmaur M, Devergne O, Auclouin J, Raphael M, Van Dumme J, et al. Interleukin-6 gene expression in Castleman's disease. Blood 1991;78:2923-30.
50. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993;20:636-17.